impact of glp-1 drugs on industries Drop More Than Just Weight Market Overview: GLP-1 Agonists and
Description
The primary endpoint was the percentage weight loss at six months (M6) compared to baseline
Glucagon-like peptide-1 receptor agonists, namely GLP-1 receptor agonists, are a class of drugs for the treatment of type 2 diabetes.
Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio
GLP-1 (Glucagon-like peptide-1) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational...
